|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ISRCTN |
|
Last refreshed on:
|
6 July 2020 |
|
Main ID: |
ISRCTN17873610 |
|
Date of registration:
|
09/10/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Viral hepatitis case-finding in primary care
|
|
Scientific title:
|
A feasibility study of case-finding strategies for the detection of Hepatitis B and C in primary care |
|
Date of first enrolment:
|
10/11/2014 |
|
Target sample size:
|
540 |
|
Recruitment status: |
Completed |
|
URL:
|
http://isrctn.com/ISRCTN17873610 |
|
Study type:
|
Interventional |
|
Study design:
|
Non-randomised; Interventional and Observational; Design type: Screening, Qualitative (Screening)
|
|
Phase:
|
Not Applicable
|
|
|
Countries of recruitment
|
|
United Kingdom
| | | | | | | |
|
Contacts
|
|
Name:
|
|
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
Sanju
Mathew |
|
Address:
|
Faculty of Health and Medical Science
GU2 7XH
Guildford
United Kingdom |
|
Telephone:
|
-- |
|
Email:
|
s.mathew@surrey.ac.uk |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
1. Practices will be selected with appropriate and eligible computer recording software
2. Practices with links to hepatology speciality services to provide support and onward referral
3. Practices with resource abilities to offer testing strategies
Exclusion criteria:
1. Practices without adequate computer records software
2. Practices without computer-linked results recording to laboratory services
Age minimum:
Age maximum:
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
Topic: Primary Care; Subtopic: Hepatology, Primary care; Disease: All Diseases
Haematological Disorders
|
|
Intervention(s)
|
New-patient testing: New patient registrations will be asked additional questions relating to HBV and HCV risks.
Testing will be offered based on risk.
Opportunistic testing, At-risk patients will be offered HBV and HCV testing when presenting to GP practices for related/unrelated reasons
Systematic testing, GP practices will identify at-risk groups in their patient population using MIQUEST coding. Written invites will be sent to patients to offer HBV and HCV testing
Follow Up Length: 3 month(s); Study Entry : Other; Details: Practices will be recruited with the help of the PCRN team
|
|
Primary Outcome(s)
|
Uptake of testing for Hepatitis B / C; Timepoint(s): The uptake of testing in intervention arms compared to control
(usual care). Over 3 months
|
|
Secondary Outcome(s)
|
1. Acceptability of testing intevention; Timepoint(s): at end of testing period (3 months)
2. Positive cases for HBV and HCV; Timepoint(s): Over 3 months
|
|
Source(s) of Monetary Support
|
|
Gilead Sciences Inc (USA) - Grant Codes: 999/UK/13-05/CI/1010
|
|
Ethics review
|
Status:
Approval date:
Contact:
14/EE/1159; First MREC approval date 25/09/2014
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
|
|
Date Completed:
|
16/02/2015 |
|
URL:
|
|
|
|